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Abstract
Background and Aims: Clostridium (Clostridiodes) difficile clade 3 ribotype (RT)
023 strains that fail to produce black colonies on bioMérieux ChromID agar have
been reported, as well as variant strains of C. difficile that produce only toxin A.
We have recently isolated strains of C. difficile from the environment in Western
Australia (WA) with similar characteristics. The objective of this study was to characterize these strains. It was hypothesized that a putative β-glucosidase gene was
lacking in these strains of C. difficile, including RT 023, leading to white colonies.
Methods and Results: A total of 17 environmental isolates of C. difficile from garden soil and compost, and gardening shoe soles in Perth, WA, failed to produce black
colonies on ChromID agar. MALDI-TOF MS analysis confirmed these strains as C.
difficile. Four strains contained only a tcdA gene (A+B−CDT−) by PCR and were a
novel RT (QX 597). All isolates were susceptible to all antimicrobials tested except
one with low-level resistance to clindamycin (MIC = 8 mg/L). The four tcdA-positive
strains were motile. All isolates contained neither bgl locus but only bgl K or a putative β-glucosidase gene by PCR. Whole-genome sequencing showed the 17 strains
belonged to novel multi-locus sequence types 632, 848, 849, 850, 851, 852 and 853,
part of the evolutionarily divergent clade C-III. Four isolates carried a full-length
tcdA but not tcdB nor binary toxin genes.
Conclusions: ChromID C. difficile agar is used for the specific detection of C. difficile in the samples. To date, all strains except RT 023 strains from clinical samples
hydrolyse esculin. This is the first report to provide insights into the identification of
esculin hydrolysis negative and TcdA-only producing (A+B−CDT−) strains of C. difficile from environmental samples.
Significance and Impact of the Study: White colonies of C. difficile from environmental samples could be overlooked when using ChromID C. difficile agar, leading to false-negative results, however, whether these strains are truly pathogenic
remains to be proven.

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any
medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
© 2022 The Authors. Journal of Applied Microbiology published by John Wiley & Sons Ltd on behalf of Society for Applied Microbiology.
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I N T RO DU CT ION
Clostridium (Clostridioides) difficile is a Gram-positive, opportunistic, spore-forming, anaerobic bacterium, the etiological agent of antimicrobial-associated diarrhoea and
pseudomembranous colitis in hospitalized patients (Smits
et al., 2016). However, increasing rates of community-
associated C. difficile infection (CA-
CDI), accounting
for up to 50% of all CDI cases in the United States (Guh
et al., 2020) and 26% of cases in Australia (Slimings
et al., 2014), suggest exposure to various sources of C. difficile external to the healthcare system such as soil, water
and wastewater, seafood, animals, meat and meat products and vegetables (Bloomfield & Riley, 2016; Hensgens
et al., 2012). There have been reports of overlapping ribotypes (RTs) of C. difficile found in animals and humans
(Anderson et al., 2017; Jhung et al., 2008) suggestive of
zoonotic transmission (Jhung et al., 2008; Rupnik, 2007).
The application of compost and manure containing C. difficile to gardens has led to the dissemination of C. difficile
in the domestic environment (Dharmasena & Jiang, 2018;
Shivaperumal et al., 2020), and contamination of vegetables (Lim et al., 2018a; Metcalf et al., 2010). Also, shoe
soles are likely to carry C. difficile from gardens of all types
into the built environment including healthcare systems
(Janezic et al., 2018; Shivaperumal et al., 2020).
Chromogenic agars have become popular bacteriological media for the isolation of a variety of pathogens
from clinical and environmental sources, including C.
difficile. C. difficile ChromID™ agar (bioMérieux, Marcy
l’Etoile, France) gives black colonies of C. difficile in
24 h following hydrolysis of the substrate and a reaction with ferric citrate (Eckert et al., 2013). Production
of distinct black colonies on ChromID agar improves
the presumptive identification of C. difficile from complex samples (Connor et al., 2016). To date, at least one
clinically relevant ribotype (RT) of C. difficile, RT 023,
a binary toxin-positive (CDT+) strain, produces colourless colonies on ChromID agar after anaerobic incubation (Connor et al., 2016). It was hypothesized that bglA
cluster 1 (encoding β-glucosidase) was associated with
the white colony phenotype (Shaw et al., 2020) and that
the phenotype may depend on the presence of another
putative β-glucosidase gene in these strains of C. difficile
(Connor et al., 2016).
In a recent study of home gardens in Perth, Western
Australia (WA), 17 strains of C. difficile were recovered that failed to produce black colonies on C. difficile

ChromID™ agar (Shivaperumal et al., 2020). The objective of the present study was to further characterize these
strains phenotypically and genotypically.

MATERIALS AND METHODS
Strains
The 17 putative esculin hydrolysis-negative strains of C.
difficile, all isolated in Perth, WA, together with comparator strains, are shown in Table 1.

Confirmation of strain identity
MALDI-
TOF MS was carried out as described previously by Schulthess et al. (2013). Analysis of mass spectra
was performed with a Microflex LT mass spectrometer
(Bruker Daltonik) using the MALDI-bioTyper 3.0 software
(Bruker Daltonics). The isolates were tested using C. diff
Quik Chek Complete® (Techlab), a rapid membrane enzyme immunoassay (EIA) for the simultaneous detection
of C. difficile glutamate dehydrogenase (GDH) and toxins
A and B. A volume of 25 μl of a 48 h brain heart infusion
broth culture (1 McFarland unit turbidity) and appropriate controls were used according to the manufacturers'
instructions. All isolates were further confirmed using l-
proline aminopeptidase DIATABS™ (Rosco Diagnostica)
as described by the manufacturer.

Phenotypic characteristics
Motility
Motility assays were conducted according to the procedure
described by (Hong et al., 2019). Briefly, isolates and esculin hydrolysis-positive (R20291) and -negative (R10725)
controls were cultured on blood agar incubated anaerobically for 48 h. Brain heart infusion broth with 0.175% agar
in test tubes was inoculated with a 1 μl loopful of colonies
by stabbing the top 5 mm of sloppy agar with the loop. The
tubes were incubated anaerobically at 37°C for 24 h and
growth was monitored. Motility was described by the distance of movement of bacteria from the inoculation line
in the low concentration agar and scored as nonmotile
(0–2 mm), motile (2–5 mm) and highly motile (>5 mm).
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Summary of C. difficile and comparator strains analysed in this study

Strain

Ribotype

Toxin profile

Sequencetype

Reference

Source

HGP05

125

A-B-CDT-

848

Shivaperumal et al. (2020)

Soil

HGP07

UNIQUE

A-B-CDT-

849

Shivaperumal et al. (2020)

Soil

HGP14

QX597

A + B-CDT-

632

Shivaperumal et al. (2020)

Soil

HGP19

125

A-B-CDT-

848

Shivaperumal et al. (2020)

Soil

HGP28

QX639

A-B-CDT-

850

Shivaperumal et al. (2020)

Soil

HGP30

QX597

A + B-CDT-

632

Shivaperumal et al. (2020)

Soil

HGP33

QX597

A + B-CDT-

632

Shivaperumal et al. (2020)

Shoe sole

HGP34

QX638

A-B-CDT-

851

Shivaperumal et al. (2020)

Soil

HGP35

QX639

A-B-CDT-

850

Shivaperumal et al. (2020)

Soil

HGP43

125

A-B-CDT-

848

Shivaperumal et al. (2020)

Compost

HGP46

QX637

A-B-CDT-

852

Shivaperumal et al. (2020)

Soil

HGP47

UNIQUE

A-B-CDT-

853

Shivaperumal et al. (2020)

Soil

HGP48

QX637

A-B-CDT-

852

Shivaperumal et al. (2020)

Soil

HGP71

125

A-B-CDT-

848

Shivaperumal et al. (2020)

Compost

HGP78-1

QX597

A + B-CDT-

632

Shivaperumal et al. (2020)

Soil

HGP78-2

125

A-B-CDT-

848

Shivaperumal et al. (2020)

Soil

848

HGP79

125

A-B-CDT-

Shivaperumal et al. (2020)

Compost

R8375

002

A+B+CDT−

N/A

ECDC

Clos di 21

023

A+B+CDT+

N/A

ECDC

−

+ +

R11446

014

A B CDT

N/A

ECDC

2149/ATCC 43600

014

A+B+CDT−

N/A

ECDC

−

− +

1470 / ATCC 43598

017

A B CDT

N/A

ECDC

R10725

078

A+B+CDT+

N/A

ECDC

R20291 / NCTC 13366

027

+ +

+

N/A

ECDC

+ +

−

A B CDT

VPI 10463 / ATCC
43255

087

A B CDT

N/A

ECDC

CD630 / ATCC
BAA-1382™

012

A+B+CDT−

N/A

ECDC

ES1213

251

A+B+CDT+

Wehrhahn et al. (2019)

Human

In vitro antimicrobial susceptibility testing
Minimum inhibitory concentrations (MICs) of a panel
of nine antimicrobial agents were determined using
the agar dilution method as described by the Clinical
and Laboratory Standard Institute (CLSI) (CLSI, 2013;
CLSI, 2019). Brucella agar supplemented with hemin
[5 μg/ml], vitamin K1 [1 μg/ml] and laked sheep blood
[5%, vol/vol] was used with a slight modification of the
CLSI guidelines (CLSI, 2007), and laked horse blood was
used. The panel consisted of the first-line therapy drugs
for CDI; vancomycin, metronidazole and fidaxomicin,
together with clindamycin, erythromycin, moxifloxacin,
amoxicillin-clavulanate, meropenem and rifampin. MIC
breakpoints for vancomycin and metronidazole were based
on the recommendations of the European Committee on
Antimicrobial Susceptibility Testing (EUCAST) (http://

eucast.org). A MIC breakpoint of ≥1 mg/L for fidaxomicin
was based on the European Medicines Agency (EMA)
proposal (report WC500119707; http://www.ema.europa.
eu/) while the breakpoints for clindamycin, erythromycin,
amoxicillin-
clavulanate, moxifloxacin and meropenem
were those provided by the CLSI (CLSI, 2013). Breakpoints
for rifampin have not been published by CLSI and susceptibility was categorized according to MICs (⩽0.002 mg/L,
susceptible; 0.003–32 μg/ml, intermediate and >32 μg/ml,
resistant) (Curry et al., 2009).

Growth kinetics assay
The toxin A (A + B-CDT-) positive isolates and comparator strains CD630/ATCC BAA-1382 (RT 012), a historic
low toxin producer, ATCC 700057 (RT 038), a known
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nontoxigenic strain, ATCC 43255 (RT 087), a known high
toxin producer and Clos di 21 (RT 023), a known white
colony producing strain were used as reference strains
for growth kinetics assays. Preparation of a standard inoculum and the C. difficile growth kinetics assays were
performed in triplicate according to methods described
elsewhere (Hong et al., 2019).

Bgl gene PCR
C. difficile crude template DNA was prepared by resuspension of 48 h culture cells in a 5% Chelex-1 00®
resin (Biorad) solution. PCR was used to characterize the esculin hydrolysis-
n egative C. difficile isolates by determining the presence of a β-glucosidase
gene. Primers were designed for detecting the gene
using the NCBI Primer-BLAST software programme
https://www.ncbi.nlm.nih.gov/tools/  p rime  r - b last/
index.cgi. The primer sequences were verified using
http://insili co.ehu.es/PCR/index.php?mo=Clostr idium; the novel primers were putative bgl F (forward:
5′-GGAGGTTGGTTAGTTTTAGA-3 ′ [20 bp]), putative bgl R (reverse: 5′-AGGATACCATTCTTGAGCT-3 ′
[19 bp]). Reaction mixes (total volume of 25 μl) consisted of 5 μl of template DNA, 4 mM MgCl 2, 400 μM
dNTP, 0.4 μM of each primer, 3.75 U AmpliTaq Gold®
DNA polymerase and 0.024% BSA. Reactions were run
with an initial denaturation step of 94°C for 3 min, followed by 35 amplification cycles of 93°C for 15 s, 50°C
for the 30 s and 68°C for 30 s with the final extension
step of 68°C for 10 min. PCR product (size 1131 bp)
was analysed on the QIAxcel Advanced capillary gel
electrophoresis platform (QIAGEN, Venlo). Esculin
hydrolysis-positive strains from clade 1 (RT 012 and
RT 014), clade 2 (RT 027 and RT 251), clade 4 (RT 017)
and clade 5 (RT 078) were used as positive controls
while the RT023 esculin hydrolysis-
n egative strain
from clade 3 and ultra-pure H 2O were the negative
controls.

Genome analysis
Whole-genome sequencing (WGS) was performed on
all 17 esculin hydrolysis-negative strains of C. difficile.
Genomic DNA extraction, library preparation, WGS
(Illumina NovaSeq), and assembly and annotation of
draft genomes were performed as previously described
(Knight et al., 2019). Evolutionary relatedness between the esculin hydrolysis-negative strains was determined by multi-locus sequence typing (PubMLST,
https://pubmlst.org/cdifficile/), and core genome

single-
nucleotide polymorphism (cgSNP) analysis
(Knight et al., 2019).
A neighbour-joining tree of concatenated MLST alleles was generated in MEGA v10 and annotated using
iToL v4 [https://itol.embl.de/]. ResFinder, Phaster and
Artemis were used to identify and characterize accessory AMR loci, phages and toxin genes respectively.
WGS data have been submitted to the NCBI Short Read
Archive under Bioproject PRJNA772357 (accessions
SAMN22374628-SAMN22374644).
The complete PaLoc sequence was extracted from the
genome of C. difficile strains 630 [GenBank Accession
Number AM180355.1], RA09-
70 [GenBank Accession
Number JPPA00000000, (Monot et al., 2015)] and the 17
esculin hydrolysis-negative strains and annotated using
Prokka v1.13.3 (https://github.com/tseemann/prokka).
The extracted segments were compared and visualized using Clinker v0.0.12 (https://github.com/gamcil/
clinker).

Statistical analysis
Statistical analysis was performed using GraphPad
Prism 5.01 software [GraphPad Software]. One-
way
analysis of variance (ANOVA) followed by Tukey’s
Multiple Comparison Test was used to assess the significance in growth rates in each strain and the comparator
strains.

RESULTS
Phenotypic characterization
All 17 putative esculin hydrolysis-negative strains failed
to produce distinctive black colonies characteristic of
C. difficile on bioMérieux ChromID plates after 24 or
48 h anaerobic incubation. The colonies were white
and umbonate, with irregular edges, and otherwise resembled those of C. difficile RT 023 (Figure 1). Using a
MALDI Bio-Typer, all strains were identified as C. difficile, and all were positive for the detection of L-proline
aminopeptidase.

Glutamate dehydrogenase, toxin
production, toxin gene PCR and ribotyping
All 17 isolates produced GDH, four (24%) were toxigenic
and, by PCR ribotyping, had similar banding patterns;
these were given an internal RT of QX 597. Six isolates
were nontoxigenic RT 125. The remaining seven isolates
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were also nontoxigenic: five were also given a QX prefix,
QX 637 (two strains), QX 638 and QX 639 (two strains),
and two were unique singletons having never been seen
before in our laboratory. No binary toxin genes were present (Table 1).

RT012 (Clade 1)

RT027 (Clade 2)

RT023 (Clade 3)

RT017 (Clade 4)

RT078 (Clade 5)

|
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Growth kinetics
Growth kinetics assays for esculin hydrolysis-positive and
-negative strains of C. difficile were performed to define
any differences in growth characteristics (Figure 2). While
there was no growth in the first 6 h, there were obvious
differences during log and stationary phases between
different strains. The cell density increased from 9 h for
the control strains VPI10463 and Clos di 21/RT 023, and
at 15 h in the esculin-negative variant strains. At 18 h,
VPI10463 attained its maximum growth compared to
Clos di 21, VPI11186 and CD630. However, the duration
of the log phase in the control strains was similar except
for VPI11186. The esculin hydrolysis-negative strains had
a prolonged exponential phase (13 h) and diminished
growth was observed throughout the 36 h period compared to control strains tested. The highest cell density
of the esculin-negative isolates was only one-third of the
control strain, VPI10463. Thus, while the overall growth
rate of esculin-negative strains was not significantly different to CD630 and VPI11186, it was when compared
with the control strains Clos di 21 (p < 0.05) and VPI10463
(p < 0.001).

RT010 (Clade 1) ‡

Motility
QX597 (Clade C-III) ‡

QX597 (Clade C-III) ‡

F I G U R E 1 C. difficile colonies on C. difficile ChromID agar.
Standard black colonies produced by esculin hydrolysis-positive
strains of C. difficile clade 1 (RT012), clade 2 (RT027), clade 4
(RT017), clade 5 (RT078) and garden strain‡ RT010, on ChromID.
Colourless colonies produced by esculin hydrolysis-negative strains
of C. difficile clade 3 (RT023) and garden strain QX597
0.8

HGP14
HGP30
HGP33
HGP78
Clos di 21
CD630
VPI 10463
VPI 1186
Negative control

7

***

6

**

5
AUC (OD600)

OD600

0.6

Motility was examined by stab inoculation into standard
motility agar (0.175%) assessing swimming motility after
24 h incubation. Ten isolates including four toxin A-
positive strains displayed a high diffusion of growth away
from the stab inoculum suggesting a high motile phenotype (mean projection length = 7 mm), whereas seven isolates appeared as average motility with a projection length
of 3 mm and two isolates were nonmotile (mean projection
length = 1.5 mm). C. difficile strains R20291 (RT 027) and

0.4

4
3
2

0.2

1

ro
co

nt

86
N

eg

at
ive

63

I1
11
VP

I1
04

D

1

63
0

VP

C

di
2

8
C

lo

s

P7

P3

G
H

H

3

l

40

0

35

G

30

H

25

P3

20
Time (h)

G

15

4

10

H

5

P1

0

G

0.0

F I G U R E 2 Growth kinetics of esculin hydrolysis-negative and reference strains. The growth of strain clos di 21 (RT023), VPI10463
(RT087), CD630 (RT012), VPI11186 (RT038) and esculin hydrolysis strains was measured by OD600 up to 36 h
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with different STs suggesting genetic heterogeneity, for
example, postcode 6024—ST848 (different soil samples
and compost, RT 125), ST632 (soil, RT QX597), postcode
6152—ST852 (soil, RT QX637) and postcode 6152—ST853
(soil, unique RT), postcode 6009—ST850 (soil, RT QX639)
and postcode 6009—ST851 (soil, RT QX638). However,
some strains showed clustering in distant postcodes without a temporal relationship, for example, postcodes 6152
(ST853, soil, unique RT), 6059 (ST849, soil, unique RT),
6163 (ST848, soil, RT 125), 6014 (ST848, compost, RT 125),
6151 (ST848, compost, RT 125), 6024 (ST848, soil and compost, RT 125). Similarly, toxin A-positive isolates (soils and
shoe sole sample, postcodes 6024, 6054 and 6006, ST632,
RT QX597) were notably clustering with nontoxigenic
Antimicrobial susceptibility
strains (soils, postcode 6152, RT QX637). This information
suggests these strains shared a recent ancestry and possiAll isolates were susceptible to metronidazole, fidaxomicin, erythromycin, moxifloxacin, amoxicillin- ble long-range transmission.
Confirming the PCR result of four strains positive for
clavulanate and rifampin. Fidaxomicin (MIC50/MIC90/
one of the major virulence factors (tcdA), in silico analGMs, 0.12/0.25/0.16 mg/L) and metronidazole (MIC50/
ysis confirmed that all toxigenic strain genomes were
MIC90/GMs, 0.5/0.5/0.38 mg/L) were the most popositive for full-length tcdA but negative for tcdB and cdtent agents and a range of MICs was seen (fidaxomicin:
tA/B. Also, syntenic holin genes uviA and uviB were found
MICrange = 0.25–0.5; metronidazole: MICrange = 0.06–0.25.
next to tcdA in all four toxin A PaLocs (Figure 4). A comAlthough elevated MICs were not observed for clindamyplete PaLoc was absent in the remaining 13 nontoxigenic
cin for most isolates (65%, 11/17), five (29%) showed instrains. Among the 17 strains, seven STs demonstrated altermediate susceptibility (MIC = 4 mg/L) and one (6%)
lelic conservations in some housekeeping genes and some
showed resistance (MIC = 8 mg/L). While three isolates
differed by polymorphisms.
were resistant (MIC = 8 mg/L) to meropenem (MIC50/
MIC90/GMs, 4/8/4.52 mg/L), almost 75% of the toxigenic
In concordance with the phenotypic testing, in silico
strains were resistant to clindamycin (MIC50/MIC90/GMs,
antimicrobial resistance (AMR) profiling demonstrated
2/4/1.84 mg/L) (Table 2).
that all 17 sequenced genomes did not contain accessory
genes conferring AMR.
Genomes of esculin hydrolysis-negative strains were
Genome analysis
screened by PCR for a β-glucosidase gene encoding hydrolase activity. In the black colonies producing strains from
WGS was successfully performed on the 17 environmenclades 1, 2, 4 and 5, a 1131 bp putative β glucosidase gene
tal strains. Genome metrics and general genomic features
fragment was found whereas clade 3 RT 023 and all the
esculin hydrolysis-negative isolates did not contain such
evaluated are shown in Table 3. Variations in genome
a fragment.
size and content were found in all 17 genomes with sizes
A threshold of 0–2 cgSNPs was used to determine
ranging from ~4.1 to ~4.5 Mb (median 4.18) and the GC
clonal relatedness among the isolates (Eyre et al., 2017;
percentage ranging between 28.23 and 28.56% (median
Knight et al., 2017). A heatmap of pairwise cgSNPs dif28.41). An MLST phylogeny for the 17 esculin hydrolysis-
ferences between all 17 genomes is shown in Table 5.
negative strains is shown in Table 4. The 17 genomes
sequenced belonged to one of seven novel STs within evoOverall, 11.8% (2/17) of strains showed a clonal relalutionarily divergent clade C-III: STs 632, 848, 849, 850,
tionship between the strains and 75% (n = 3) of compost
851, 852 and 853 (Figure 3). All tcdA-positive isolates
samples showed a clonal relationship (2 cgSNPs, ST848)
(novel RT QX597, n = 4) belonged to ST632. The predomiwith other compost samples (n = 4) from two suburbs
nant RT among the 17 strains (RT 125, n = 6) belonged to
(~12 km distance). Other strains showed a relatively
ST848 and the unique RTs belonged to STs 853 (n = 1) and
close relationship among soil (n = 2) and composts
849 (n = 1). The remaining five isolates belonged to three
(n = 4) samples from three suburbs (~3–10 cgSNPs,
unique STs (STs 850, n = 2, 851, n = 1 and 852, n = 2). All
an average of 15 cgSNPs between strains with an averseven STs belonged to evolutionary clade C-III (Table 4).
age distance of ~43 km away) and compost (n = 4) and
A few strains that shared postcodes and a temporal
soil (n = 3) from six suburbs (~11–20 cgSNPs, an averrelationship were located in distant parts of phylogeny
age of 13.5 cgSNPs, ~65 km) in WA. All these strains
R10725 (RT 078) were used as positive and negative controls respectively. While the positive control R20291 was
highly motile (mean projection length = 8 mm), negative
control, R10725 was nonmotile, with an average projection
length of 1.5 mm. All the isolates were further confirmed
by a hanging drop motility test. The flagellin fliC and flagellar cap fliD genes were conserved in all strains including in toxin A-positive strains. All isolates contained F1
(late-stage flagella genes), F3 (early-stage flagella genes)
and four additional late-stage flagella genes including in
reference strains (RT 027, RT 023 and RT 012).

0.12

0.25

0.12

0.25

0.25

0.25

0.25

0.12

0.12

0.12

0.12

0.12

0.25

0.12

0.25

0.25

0.06

0.015

>4
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>4

HGP05
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HGP33
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HGP71

HGP78-1

HGP78-2

HGP79

C. difficile 700,057

B. fragilis 25,285

E. lentum 43,055

B. thetaiotamicron
29,741

-

I
≤2

>2

>4

0.25

0.5

0.125

0.25

0.5

0.25

0.5

0.5

0.25

0.5

0.5

0.5

0.5

0.25

0.25

0.5

0.5

0.25

0.5

0.25

S

R

MTZ

-

I
>2

R

1

0.06

0.25

0.004

0.5

4

4

4

8

1

8

4

2

4

4

4

4

1

4

2

2

S

RIF
I
≥32

R

2

0.125

1

8

1

4

8

0.5

2

4

2

2

0.5

2

4

4

0.5

0.5

2

2

4

≤2

S

CLI

4

I
≥8

R

16

0.25

16

1

0.25

0.5

1

0.25

1

1

1

0.5

1

0.5

1

1

1

0.5

1

0.5

0.5

-

S

ERY

-

I
>8

R

0.25

0.5

0.25

0.5

0.5

0.5

0.25

0.5

0.5

0.5

0.5

0.5

0.5

0.5

0.25

0.25

0.5

0.5

0.25

0.5

0.25

≤4

S

AMC

8

I
≥16

R

1

0.25

0.25

2

1

1

1

1

1

1

1

1

2

1

2

1

2

1

2

1

1

≤2

S

MXF

4

I
≥8

R

<0.25

0.5

<0.25

2

4

4

4

4

4

4

8

4

8

4

4

4

8

4

4

4

4

≤4

S

MEM

8

I

Breakpoints for fidaxomicin recommended by EMA (report WC500119707, http://www.ema.europe.eu/) (European Medicines Agency, 2011), for vancomycin and metronidazole recommended by EUCAST
(EUCAST, 2020), remaining as recommended by CLSI (CLSI, 2013).

a

Note: S, susceptible; I, intermediate; R, resistant. ATCC700057 (C. difficile) and ATCC25285 (Bacteroides fragilis) strains were controls as recommended by CLSI. FDX, fidaxomicin; VAN, vancomycin; MTZ,
metronidazole; RIF, rifampin; CLI, clindamycin; ERY, erythromycin; AMC, amoxicillin-clavulanate; MXF, moxifloxacin; MEM, meropenem.

>4

2

>4

2

2

2

2

2

1

2

1

2

2

2

2

2

2

2

2

2

2

≤2

-

-

Strain

≥1

S

I

S

R

VAN

Antimicrobial breakpoint (mg/L)a

Antimicrobial susceptibility analysis

FDX

TABLE 2

≥16

R
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TABLE 3
Strain

Genome metrics
ENA accession

N contigs

Total length (bp)

N50 (bp)

Median
seq depth

GC (%)

HGP05

SAMN22374628

13

4,138,029

3,844,413

28.48

55.26

HGP07

SAMN22374629

14

4,119,880

3,757,367

28.51

77.33

HGP14

SAMN22374630

81

4,241,508

93,313

28.45

99.15

HGP19

SAMN22374631

14

4,136,262

3,782,574

28.45

45.83

HGP28

SAMN22374632

12

4,243,128

3,951,787

28.38

36.77

HGP30

SAMN22374633

92

4,265,720

92,878

28.42

101.48

HGP33

SAMN22374634

13

4,249,315

3,787,856

28.48

80.19

HGP34

SAMN22374635

11

4,237,441

2,696,177

28.44

68.39

HGP35

SAMN22374636

16

4,241,733

3,836,539

28.38

33.77

HGP43

SAMN22374637

13

4,137,439

3,843,029

28.47

93.05

HGP46

SAMN22374638

9

4,192,908

3,967,814

28.23

48.57

HGP47

SAMN22374639

12

4,511,861

4,285,437

28.33

29.15

HGP48

SAMN22374640

10

4,206,389

3,980,098

28.28

107.63

HGP71

SAMN22374641

13

4,146,017

3,852,144

28.47

60.05

HGP78-1

SAMN22374642

77

4,485,801

104,641

28.24

95.72

HGP78-2

SAMN22374643

13

4,171,210

3,877,171

28.41

28.68

HGP79

SAMN22374644

13

4,181,177

3,842,470

28.42

38.25

TABLE 4

MLST data

Strain

ST

Clade

Adk

atpA

Dxr

glyA

recA

sodA

Tpi

HGP05

848

C-III

86

89

86

125

73

100

106

HGP07

849

C-III

87

89

86

125

73

101

106

HGP14

632

C-III

57

61

61

90

50

71

83

HGP19

848

C-III

86

89

86

125

73

100

106

HGP28

850

C-III

88

39

54

57

74

50

56

HGP30

632

C-III

57

61

61

90

50

71

83

HGP33

632

C-III

57

61

61

90

50

71

83

HGP34

851

C-III

89

90

87

126

75

102

107

HGP35

850

C-III

88

39

54

57

74

50

56

HGP43

848

C-III

86

89

86

125

73

100

106

HGP46

852

C-III

23

91

88

127

76

37

108

HGP47

853

C-III

87

89

86

128

77

103

106

HGP48

852

C-III

23

91

88

127

76

37

108

HGP71

848

C-III

86

89

86

125

73

100

106

HGP78-1

632

C-III

57

61

61

90

50

71

83

HGP78-2

848

C-III

86

89

86

125

73

100

106

HGP79

848

C-III

86

89

86

125

73

100

106

Source: 1 (soil); 2 (shoes); 3 (compost), ST: Sequence type, RT: Ribotype, TP: Toxin profile.

belonged to RT 125 and the new ST (848). However, all
the toxigenic isolates (n = 5) from three suburbs (~10–
32 cgSNPs, an average of 19.1 cgSNPs, ~28 km) belonged
to a novel RT (597) and a new ST (632). All these strains
shared recent evolutionary history.

DISC USSION
Recently, there has been an increased incidence of CA-
CDI, now comprising ~50% of all CDI cases in the USA
(Guh et al., 2020) and suggesting that sources of C. difficile

UNUSUAL STRAINS OF C. DIFFICILE IN THE ENVIRONMENT

  

|

1191

Clade 1
Clade 2
Clade 3
Clade 4
Clade 5
Clade C-I
Clade C-II
Clade C-III

ST
620
200
637
311
360
181
178
644
180
649
853
849
848
851
852
632
850
369

0·01

343

F I G U R E 3 Global phylogenetic context of seven novel sequence types. MLST phylogeny based on concatenated allele sequences for
seven novel sequence types (cryptic clade C-III) and well-characterized representatives of MLST clade 1 (ST54, RT012), clade 2 (ST1, RT027),
clade 3 (ST22, RT023), clade 4 (ST37, RT017), clade 5 (ST11, RT078), as well as other cryptic clades C-I (ST360) and C-II (ST200). The scale
shows the number of substitutions per site

tcdR

tcdA

uviB

RA09-70

HGP14

F I G U R E 4 PaLoc structure of
tcdA-positive isolates of C. difficile from
environmental samples. Mono-toxin
PaLoc of environmental isolates (e.g.
HGP14) shared synteny and a high
nucleotide sequence similarity to the
PaLoc of clinical isolate RA09-70 (clade 5)

CD630

tcdR

tcdE uviB

tcdB

2.5kb

0

Identity (%)

tcdC

tcdA

100
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TABLE 5

Core genome SNP analysis

Heatmap of pairwise core genome SNP differences between 17 isolates:

0-20,

21-100,

101-3000,

3001-6000 and

6001-7000.

a

ST: Sequence type, bRT: Ribotype, cTP: Toxin profile, dSource: 1 (soil); 2 (shoes); 3 (compost).

[Correction added on 20th April 2022, after first online publication: Table 5 footnotes have been included]

causing disease can be diverse (Eyre et al., 2013). In addition, C. difficile is now a ubiquitous environmental organism (Moono et al., 2017; Rodriguez et al., 2018). Produced
by bioMérieux, ChromID C. difficile agar has become popular for rapidly putatively identifying C. difficile from both
clinical and environmental samples (Eckert et al., 2013;
Perry et al., 2010). C. difficile RT 023 is a clinically important strain of C. difficile that fails to produce distinctive
black colonies on ChromID C. difficile agar plates (Connor
et al., 2016). Recently, we reported similar strains of C.
difficile producing atypical white colonies on ChromID C.
difficile agar isolated from environmental samples. Of 87
strains of C. difficile recovered in that study, 17 (19.5%)
were esculin hydrolysis-negative and produced white colonies (Shivaperumal et al., 2020).
Hydrolysis of esculin by a β-glucosidase produces D-
glucose and esculetin (6,7-
dihydroxycoumarin) which
react with ferric ions to produce black colonies of C. difficile (Connor et al., 2016; Perry et al., 2007) and esculin
hydrolysis with ferric chloride provides a zymogram
technique to locate an appropriate β-glucosidase, esculinase (Kwon et al., 1994). The main disadvantage of using
some substrates in media is that the complex formed by
hydrolysis diffuses rapidly throughout the agar medium.
In contrast, the derivative of esculin, 3, 4-cyclohexenoes
culetin-7-β-d-glucoside (CHE- β-d-glucoside), remains
highly insoluble and nondiffusible in the medium (James
et al., 1996).
In Escherichia coli, several catabolic systems have been
explored in the utilization of aromatic glucosides such as
arbutin (Arb), salicin (Sal) and esculin (Esc) that encode a
sugar-specific permease that is a part of the phosphotransferase system (PTS) and a phospho-glucosidase necessary
for the hydrolysis of the sugar (Zangoui et al., 2015). Upon

mutational activation, the silent operon becomes functional.
For example the β-glucoside catabolic system involved in
esculin utilization is the bgl operon and, once activated, either BglF transports esculin inside the cell or phospho β-
glucosidase B encoded by bglB cleaves the phosphorylated
esculin (Zangoui et al., 2015). A phospho-β-glucosidase
gene, bglA in Streptococcus mutans UA159 genome, upon
targeted inactivation of the gene, revealed the involvement of bglA in the hydrolysis of esculin (Old et al., 2006).
A regulon from S. mutans encodes a β-glucoside-specific
Enzyme II (EII) component (bglP) and bglA, and a chromosomal deletion in both genes resulted in its inability to
hydrolyse esculin in the presence of glucose but retained its
ability to breakdown esculin with the removal of glucose in
the medium (Cote et al., 2000). In E. coli, the acquisition of
a four-nucleotide insertion in the bglA gene leads to esculin
hydrolysis resulting in enhanced steady-state levels of the
bglA transcript (Zangoui et al., 2015). In this study, we hypothesized that the esculin hydrolysis-negative strains do
not possess the locus for esculin metabolism including the
licT gene, encoding for the transcriptional regulator, bglF,
bglA and the putative β-glucosidase gene.
In C. difficile, a putative β-glucosidase gene has been
found in clades 1, 2, 4 and 5 but not in clade 3. Shaw
et al. (2020) identified five bgl clusters and putative esculinase clusters in the C. difficile strain 630 (clade 1, RT 012)
genome include bgl genes bglA, bglG and bglF (Shaw
et al., 2020). In our study, the putative β-glucosidase gene
was absent in clade 3 and esculin hydrolysis-
negative
strains from environmental samples. The absence of bglA
and bglF leads to an inability to hydrolyse esculin, however,
C. difficile still utilizes carbohydrates from other sources.
The toxin bands in the C. diff Quik Chek Complete
assay were weak for four strains with one showing
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moderate intensity which has been described for a toxin
A only positive (A + B-CDT-) clinical strain of C. difficile (Monot et al., 2015). MALDI-TOF MS was used also
to confirm all isolates as C. difficile. Recent advances such
as the availability of an extensive database and validated
MALDI-TOF MS procedures showed the identification
of anaerobes at species level has become more accurate
(Kim et al., 2016). Despite these improvements in identifying bacterial pathogens at the species level, MALDI-TOF
MS has not been used frequently for C. difficile. However,
whether these strains are truly C. difficile is debatable
given our recently published taxonomic study that suggests the cryptic clades are likely new species (Knight
et al., 2021).
PCR ribotyping of all esculin-negative isolates demonstrated seven distinct RTs, including approximately one-
third RT 125 (35.3%, 6/17) together with several novel RTs
(Shivaperumal et al., 2020). In this study, in particular, we
describe and characterize four isolates of toxigenic A + B-
CDT- C. difficile from environmental samples. Monot
et al. (2015) found the PaLoc of a toxin A-positive clinical strain contained tcdR and tcdA, but no tcdB, tcdE or
tcdC genes (Monot et al., 2015). Instead, a new putative
Coding DNA Sequence (CDS) of 216 bp, a substitution of
tcdE, was found between tcdR and tcdA which encodes a
domain with 71 amino acids homologous to the bacteriophage holin protein BhlA/UviB. They proposed a classical ‘Bi-Toxin PaLoc’ from the fusion of two ‘Mono-Toxin
PaLoc’ from ancestral clostridia (Monot et al., 2015).
In a hamster model, a TcdA-
only producing strain
caused no mortality nor characteristic CDI signs including diarrhoea even though the strain was isolated originally from a patient with diarrhoea (Marvaud et al., 2019).
Histology revealed that toxin A, presumably, caused significant caecal damage, inflammation with neutrophilic
infiltration and extensive hyperplasia. It was thought that
damage and inflammation were due to TcdA and flagellin as the TcdA only positive strain had regulons coding
the flagellar proteins (Marvaud et al., 2019). In the current study, the flagellar genes fliD and fliC were present
in all the TcdA (A + B-CDT-) isolates and these proteins
are essential for functional flagella and bacterial adhesion
to host cells (Stabler et al., 2009; Stevenson et al., 2015).
An isogenic mutant producing only TcdA (A + B-CDT-)
also caused disease and mortality in hamsters, however,
this was delayed compared to A-B+ and wild-type strains
(Kuehne et al., 2010). Thus, TcdA only producing strains of
C. difficile causing human infection should not be ignored.
Fluoroquinolones, clindamycin and cephalosporins
have been associated with a high risk of CDI (Kuijper
et al., 2008). Previous studies showed high rates of resistance to clindamycin (69%) in C. difficile from pig samples even though clindamycin is not approved for use
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in food animals (Knight et al., 2017) and from compost
and lawn samples (Lim et al., 2018b). In contrast, many
esculin hydrolysis-negative strains from the present study
were susceptible to clindamycin (68%), with some showing intermediate resistance (26%), in agreement with an
earlier study from Europe (Janezic et al., 2012). In general, clindamycin-
resistant strains show resistance to
erythromycin owing to erythromycin ribosomal methylase gene class B (ermB) mediated resistance with the gene
located on mobile genetic elements (Knight et al., 2017;
Spigaglia, 2016). Notably, all isolates were susceptible to
first-line CDI treatment drugs including metronidazole,
vancomycin and fidaxomicin, similar to our earlier study
(Knight et al., 2017).
Bacterial flagella contribute to the pathogenesis of
disease through adherence, colonization and facilitating
translocation of virulence factors which play a pivotal
role in adapting to their biological niches. Flagellar motility is vital for the gastrointestinal bacteria including C.
difficile to colonize in their hosts (Stevenson et al., 2015).
The adherence of peritrichous flagella of C. difficile in
mouse cecum revealed a 10-fold increase than the adherence of nonflagellated strains (Twine et al., 2009).
In the present study, 26% of esculin hydrolysis strains
demonstrated a high level of motility compared to the
well-established epidemic strain RT 027 strain R20291. A
similar result was observed in esculin hydrolysis-negative
C. difficile RT 023 isolates in a recent study by Karpiński
et al. (2022). All toxin A producing isolates were highly
motile (>5 mm). All had the F1 (late-stage flagella genes)
and four additional genes, DTDP-
4-
dehydrorhamnose
reductase, glucose-1-phosphate thymidylyltransferase,
DTDP-4-dehydrorhamnose 3,5-epimerase and DTDP-
glucose 4,6-
dehydratase, which are believed to play a
role in virulence (Stabler et al., 2009). The F1 region of
the genome encodes the genes for the structural proteins
fliD and fliC essentially required for the formation of
fully functional flagella (Stevenson et al., 2015). The fliA
gene positively regulates the genes in the F1 region (El
Meouche et al., 2013). However, other studies suggest that
nonflagellated strains cause disease similar to flagellated
strains (Stevenson et al., 2015) and the virulence is either
RT dependent or nontraditional (Androga et al., 2019; El
Meouche et al., 2013; Stabler et al., 2009).
Using WGS and high-resolution core genome phylogenetics and cgSNPs analysis we describe the evolutionary
relationships of novel esculin hydrolysis-negative toxin
A-positive strains. In silico MLST differentiated the 17
esculin hydrolysis-negative strains into seven novel STs
(632, 848, 849, 850, 851, 852 and 853), all part of the evolutionarily divergent clade C-III. All tcdA-positive isolates
belonged to sequence type 632. All toxigenic strains contained a full-length tcdA, but were negative for tcdB and

1194

|

SHIVAPERUMAL et al.

  

cdtA/B, and the PaLoc was located in different regions of
the C. difficile genome. The insertion in the element of the
tcdA-positive strains from this study was similar to that of
the RA09-70 strain (Monot et al., 2015) (Figure 4).
Phylogenetic analysis of core genes can reveal ultrafine
resolution of C. difficile populations (Dingle et al., 2011;
Knight et al., 2017). In this study, there was diversity among
isolates by RT and suburb, for example, RTs QX 597 (ST632)
and RT 125 (ST848) were distributed in many suburbs. In
some instances, soil and compost isolates collected from
houses in different suburbs were closely related (2 cgSNPs)
in their core genome suggesting long-range transmission.
Overall, 75% of compost strains showed a clonal relationship with compost isolates from two suburbs approximately
12 km apart indicating possible contamination with animal manure of vegetables as the participants made their
compost from vegetable waste at home. There was a high
prevalence (56%) of C. difficile on root vegetables reported
recently in WA which possibly contributes to contamination of traditional composts (Lim et al., 2018a).
Bacterial growth patterns obtained for various C. difficile isolates were similar to those seen in a previous study
(Hong et al., 2019). However, the control strain VPI10463
reached exponential phase 2 h later than in the previous
report (Hong et al., 2019), although the peak growth rate
and the growth pattern were comparable. While the duration of the stationary phase was short in a high toxin
producer (VPI10463, 6 h) (Hong et al., 2019), surprisingly,
the white colony-producing strains had a prolonged stationary phase (16 h). The growth of all reference toxigenic strains was significantly better than that of CD630
(p < 0.001) (Vohra & Poxton, 2011). In this study, the
toxin A producing white colony strains were significantly
different from the control strains, Cl di 21 (p < 0.05) and
VPI10463 (p < 0.001).
Our study had some limitations. First, the esculin
hydrolysis-negative strains were found among 87 garden
isolates recovered in the suburbs of Perth, Australia. Our
results may not be reflective of the prevalence of esculin
hydrolysis-negative strains in the rest of Australia due
to the limited numbers of samples tested, and the isolation of Perth. Second, PCR for the putative β-glucosidase
gene was performed on selected RTs from each clade
and a wider range of RTs should be tested. Finally, until
recently, toxin A is often produced with toxin B in both
clinical and environmental strains. In this study, variant
strains produced only toxin A and these strains should be
tested in laboratory animals to demonstrate their pathogenicity and clinical features of any disease they cause.
In conclusion, we describe the isolation and characterization of esculin hydrolysis-negative tcdA only positive
strains of C. difficile from the environment in WA. The
white colonies seen on ChromID plates may affect the

isolation and identification of toxin A only positive strains
as they may be overlooked. A putative β-glucosidase
gene was present in all clades except clade 3 and esculin
hydrolysis-negative strains of C. difficile. The majority of
tcdA-positive isolates were motile and belonged to novel
RTs. Further investigation is required to study the occurrence of these strains in a wide range of RTs. Putative β-
glucosidase gene knock-out studies compared with the
wild type will aid in confirm the virulence of this variant
strain in laboratory animals. Toxin A producing esculin
hydrolysis-negative strains need to be taken into account
in diagnostic clinical microbiology settings.
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